Login / Signup

Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study.

Anna-Maija TolppanenMiia TiihonenHeidi TaipaleMarjaana KoponenAntti TanskanenPiia LavikainenJari TiihonenSirpa Hartikainen
Published in: Drugs & aging (2019)
There were no major differences in systemic estrogen use among Finnish women with AD when compared to those without AD. Although some persons initiated estrogen use after AD diagnosis and/or at an advanced age, the observed use patterns were mainly consistent with the current recommendations.
Keyphrases
  • estrogen receptor
  • cross sectional
  • clinical practice
  • mild cognitive impairment